These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7869358)

  • 1. Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques.
    Dittmer U; Lüke W; Stahl-Hennig C; Coulibaly C; Petry H; Bodemer W; Hunsmann G; Voss G
    J Med Primatol; 1994 Jul; 23(5):298-303. PubMed ID: 7869358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
    J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection.
    Petry H; Dittmer U; Stahl-Hennig C; Coulibaly C; Makoschey B; Fuchs D; Wachter H; Tolle T; Morys-Wortmann C; Kaup FJ
    J Virol; 1995 Mar; 69(3):1564-74. PubMed ID: 7853490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The simian immunodeficiency virus deltaNef vaccine, after application to the tonsils of Rhesus macaques, replicates primarily within CD4(+) T cells and elicits a local perforin-positive CD8(+) T-cell response.
    Stahl-Hennig C; Steinman RM; Ten Haaft P; Uberla K; Stolte N; Saeland S; Tenner-Racz K; Racz P
    J Virol; 2002 Jan; 76(2):688-96. PubMed ID: 11752159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
    Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: correlation with viremia, disease progression, and seroconversion to structural viral proteins.
    Kirchhoff F; Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Frank R; Jentsch KD; Hunsmann G
    Virology; 1991 Jul; 183(1):267-72. PubMed ID: 1675823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
    Biberfeld G; Thorstensson R; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent Simian Immunodeficiency Virus Infection Causes Ultimate Depletion of Follicular Th Cells in AIDS.
    Xu H; Wang X; Malam N; Lackner AA; Veazey RS
    J Immunol; 2015 Nov; 195(9):4351-7. PubMed ID: 26408660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response to SIVmac and HIV-2 in macaques: model for the human HIV-1 infection.
    Voss G; Hunsmann G
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):969-76. PubMed ID: 8340900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus.
    Cranage MP; Polyanskaya N; McBride B; Cook N; Ashworth LA; Dennis M; Baskerville A; Greenaway PJ; Corcoran T; Kitchin P
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):13-22. PubMed ID: 8427714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation.
    Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.
    Silverstein PS; Mackay GA; Mukherjee S; Li Z; Piatak M; Lifson JD; Narayan O; Kumar A
    J Virol; 2000 Nov; 74(22):10489-97. PubMed ID: 11044093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.